Publications by authors named "Steven Highfill"

Claim this Profile
1
10-year experience of CD22 CAR T-cells for children and young adults with B-cell acute lymphoblastic leukemia.
Alexandra Dreyzin, Bonnie Yates, Haneen N Shalabi, Sara K Silbert, Hao-Wei Wang, Steven L Highfill

Blood Adv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes following CD22 CAR T-cells in B-ALL: a tale of two manufacturing strategies.
Alexandra Dreyzin, Anne Marijn Kramer, Bonnie Yates, Hao-Wei Wang, Bita Sahaf, Steven Highfill

Cytotherapy· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunophenotype of CAR T cells and apheresis products predicts response in CD22 CAR T cell trial for B cell acute lymphoblastic leukemia.
Alexandra Dreyzin, Lipei Shao, Yihua Cai, Kyu Lee Han, Michaela Prochazkova, Steven Highfill

Mol Ther· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the impact of cell isolation method on B cell gene expression using next-generation sequencing.
Amanda N Henning, Jordan Pardoe, Darryl Owusu-Ansah, Hong Lei, Kobe Robichaux, Steven L Highfill

Exp Hematol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Novel humanized CD19-CAR-T (Now talicabtagene autoleucel, Tali-cel™) cells in relapsed/ refractory pediatric B-acute lymphoblastic leukemia- an open-label single-arm phase-I/Ib study.
Gaurav Narula, Swaminathan Keerthivasagam, Hasmukh Jain, Sachin Punatar, Akanksha Chichra, Steven Highfill

Blood Cancer J· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Talicabtagene autoleucel for relapsed or refractory B-cell malignancies: results from an open-label, multicentre, phase 1/2 study.
Hasmukh Jain, Atharva Karulkar, Devanshi Kalra, Smrithi Ravikumar, Shreshtha Shah, Steven L Highfill

Lancet Haematol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel humanized CD19-CAR-T (Now talicabtagene autoleucel, Tali-cel™) cells in relapsed/ refractory pediatric B-acute lymphoblastic leukemia- an open-label single-arm phase-I/Ib study.
Gaurav Narula, Swaminathan Keerthivasagam, Hasmukh Jain, Sachin Punatar, Akanksha Chichra, Steven Highfill

Blood Cancer J· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficient manufacturing of CAR-T cells from whole blood: a scalable approach to reduce costs and enhance accessibility in cancer therapy.
Roshini Traynor, Isabella Vignola, Sarmila Sarkar, Michaela Prochazkova, Yihua Cai, Steven L Highfill

Cytotherapy· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regression of renal cell carcinoma by T cell receptor-engineered T cells targeting a human endogenous retrovirus.
Stefan Barisic, Elizabeth M Brahmbhatt, Elena Cherkasova, Timothy T Spear, Ujjawal Savani, Steven Highfill

J Immunother Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CAR-T cell expansion platforms yield distinct T cell differentiation states.
Hannah W Song, Michaela Prochazkova, Lipei Shao, Roshini Traynor, Sarah Underwood, Steven L Highfill

Cytotherapy· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T Cell Activators Exhibit Distinct Downstream Effects on Chimeric Antigen Receptor T Cell Phenotype and Function.
Sarah Underwood, Jianjian Jin, Lipei Shao, Michaela Prochazkova, Rongye Shi, Steven L Highfill

Immunohorizons· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcoma.
Meijie Tian, Jun S Wei, Nityashree Shivaprasad, Steven L Highfill, Berkley E Gryder

Cell Rep Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deciphering the importance of culture pH on CD22 CAR T-cells characteristics.
Michaela Prochazkova, Alexandra Dreyzin, Lipei Shao, Pam Garces, Yihua Cai, Steven L Highfill

J Transl Med· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Manufacture of CD22 CAR T cells following positive versus negative selection results in distinct cytokine secretion profiles and γδ T cell output.
Hannah W Song, Mehdi Benzaoui, Alka Dwivedi, Sarah Underwood, Lipei Shao, Steven L Highfill

Mol Ther Methods Clin Dev· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of anti-CD19 CAR T cell production for treatment of patients with chronic lymphocytic leukemia.
Christina Amatya, Katherine A Weissler, Vicki Fellowes, Norris Lam, Lauren C Cutmore, Steven L Highfill

Mol Ther Methods Clin Dev· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transient responses and significant toxicities of anti-CD30 CAR T cells for CD30+ lymphomas: results of a phase 1 trial.
Jennifer N Brudno, Danielle A Natrakul, Jeremiah Karrs, Nisha Patel, Roberto Maass-Moreno, Steven L Highfill

Blood Adv· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment and comparison of viability assays for cellular products.
Yihua Cai, Michaela Prochazkova, Yong-Soo Kim, Chunjie Jiang, Jinxia Ma, Steven L Highfill

Cytotherapy· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid anti-myeloma activity by T cells expressing an anti-BCMA CAR with a human heavy-chain-only antigen-binding domain.
Lekha Mikkilineni, Danielle A Natrakul, Norris Lam, Elisabet E Manasanch, Jennifer Mann, Steven L Highfill

Mol Ther· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune determinants of CAR-T cell expansion in solid tumor patients receiving GD2 CAR-T cell therapy.
Sabina Kaczanowska, Tara Murty, Ahmad Alimadadi, Cristina F Contreras, Caroline Duault, Steven L Highfill

Cancer Cell· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcoma.
Meijie Tian, Jun S Wei, Nityashree Shivaprasad, Steven L Highfill, Berkley E Gryder

Cell Rep Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reference gene selection for clinical chimeric antigen receptor T-cell product vector copy number assays.
Jinxia Ma, Lipei Shao, Tatyana Fuksenko, Hui Liu, Rongye Shi, Steven L Highfill

Cytotherapy· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing a fully automated and closed system process for red blood cell reduction of human bone marrow products.
Victoria Ann Remley, Ashley Collins, Sarah Underwood, Jianjian Jin, Yoon Kim, Steven L Highfill

Cytotherapy· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cryopreserved anti-CD22 and bispecific anti-CD19/22 CAR T cells are as effective as freshly infused cells.
Alexandra Dreyzin, Sandhya R Panch, Haneen Shalabi, Bonnie Yates, Steven L Highfill

Mol Ther Methods Clin Dev· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Intraperitoneal Monocytes plus IFNs as a Novel Cellular Immunotherapy for Ovarian Cancer: Mechanistic Characterization and Results from a Phase I Clinical Trial.
Daniel S Green, Franklin Ning, Anna Duemler, Timothy G Myers, Kathryn Trewhitt, Steven L Highfill

Clin Cancer Res· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide profiling of retroviral DNA integration and its effect on clinical pre-infusion CAR T-cell products.
Lipei Shao, Rongye Shi, Yingdong Zhao, Hui Liu, Alexander Lu, Steven L Highfill

J Transl Med· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis